FDA Issues Warning Letter to Applied Therapeutics
December 05, 2024
December 05, 2024
WASHINGTON, Dec. 5 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Applied Therapeutics Inc.:
* * *
To: Shoshana Shendelman, Ph.D., CEO & Founder, Applied Therapeutics, Inc., 545 Fifth Avenue, Suite 1400, New York, NY 10017, United States
Dear Dr. Shendelman:
This Warning Letter informs you of objectionable conditions observed during the U.S. Food and Drug Administrati . . .
* * *
To: Shoshana Shendelman, Ph.D., CEO & Founder, Applied Therapeutics, Inc., 545 Fifth Avenue, Suite 1400, New York, NY 10017, United States
Dear Dr. Shendelman:
This Warning Letter informs you of objectionable conditions observed during the U.S. Food and Drug Administrati . . .